Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I (NPTUNE 02)
Phase I/IIa Clinical Trial of Sodium Phenylbutyrate in Pediatric Subjects With Type I Spinal Muscular Atrophy
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Terminated
Extremely slow enrollment
Other terminated trials from National Institute of Neurological Disorders and Stroke (NINDS)
- Nervous System Diseases · Apr 2025
- Parkinson Disease Dementia · Phase NA · Feb 2025
- Muscle Spasticity · Phase NA · Jun 2024
- Acute Ischemic Stroke · Jan 2023
- Diagnostic Imaging · Phase PHASE2 · Dec 2021
See all terminations from National Institute of Neurological Disorders and Stroke (NINDS)
This PHASE1/PHASE2 trial investigates Spinal Muscular Atrophy Type I and is currently terminated or withdrawn. National Institute of Neurological Disorders and Stroke (NINDS) leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1_PHASE2
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- Westat
For direct contact, visit the study record on ClinicalTrials.gov .